Dr. Stoll is a board-trained hematologist and medical oncologist at Oncura Health, specializing in the treatment of cancer and blood disorders, with expertise in multiple myeloma, kidney cancer, pancreatic cancer, and neuroendocrine tumors. He is committed to delivering personalized, evidence-based oncology care tailored to each patient’s needs.

Dr. Stoll earned his medical degree from Touro University College of Osteopathic Medicine, graduating in the top ten percent of his class. During his clinical training, he completed medical rotations at Kern Medical Center, Cedars-Sinai Medical Center, as well as with physicians affiliated with Kaiser Permanente and City of Hope.

He completed his Internal Medicine residency and Hematology-Oncology fellowship at Maimonides Medical Center, where he developed advanced expertise in comprehensive cancer treatment and multidisciplinary care.

Dr. Stoll has contributed to oncology education and research, presenting lectures on topics including neuroendocrine tumors, transplant-ineligible multiple myeloma, metastatic kidney cancer, and metastatic pancreatic cancer. He is also actively involved in ongoing research exploring complementary and alternative medicine in cancer care, reflecting his interest in a more holistic approach to treatment.

At Oncura Health, Dr. Stoll focuses on helping patients navigate their diagnosis with clarity and confidence, combining clinical expertise with a thoughtful, patient-centered approach to cancer care.